Guidant Awaits SPIRIT Trial Data For Clear Vision Of Future Stent Business

Feasibility data on the Multi-Link Vision cobalt-chromium, durable-polymer, everolimus-eluting stent will be key to predicting the stability of Guidant's DES technology platform in the post-Dollens era

More from Archive

More from Medtech Insight